rs1554123702
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001999.4(FBN2):c.3196dupA(p.Thr1066AsnfsTer11) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001999.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN2 | ENST00000262464.9 | c.3196dupA | p.Thr1066AsnfsTer11 | frameshift_variant | Exon 24 of 65 | 1 | NM_001999.4 | ENSP00000262464.4 | ||
FBN2 | ENST00000508989.5 | c.3097dupA | p.Thr1033AsnfsTer11 | frameshift_variant | Exon 23 of 33 | 2 | ENSP00000425596.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital contractural arachnodactyly Uncertain:1
This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a FBN2-related disease. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in FBN2 cause disease. Therefore, this variant has been classified as a Variant of Uncertain Significance. This sequence change inserts 1 nucleotide in exon 24 of the FBN2 mRNA (c.3196dupA), causing a frameshift at codon 1066. This creates a premature translational stop signal (p.Thr1066Asnfs*11) and is expected to result in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at